Risk stratification in localized prostate cancer relies primarily on Grade group (GG). In GG2-4 disease, risk assignment depends on the proportions of pattern 3 and pattern 4. We hypothesized that ...

Althopugh current prostate cancer biomarkers have improved the detection of clinically significant disease (Gleason Grade Group 2+), they fail to distinguish between high-grade cancer and genuinely ...

Althopugh current prostate cancer biomarkers have improved the detection of clinically significant disease (Gleason Grade Group 2+), they fail to distinguish between high-grade cancer and genuinely ...

A federal judge ruled The Leapfrog Group's hospital grading methodology was unfair and deceptive, ordering the nonprofit to remove grades for 5 Palm Beach County hospitals from its website WEST PALM ...

EXCLUSIVE: Elsbeth Season 3 will welcome beloved stars Mark Linn-Baker (Succession, Perfect Strangers), Joanna Gleason (The West Wing, The Good Wife/Fight), and Didi Conn (Grease, Benson), who will ...

Decipher genomic classifier scores combined with Gleason grade group improve risk stratification for prostate cancer patients on active surveillance. Patients with GG1 and high genomic classifier ...

The FDA has approved the Vanquish Water Vapor Ablation System, which uses steam to destroy prostate tumors. However, the efficacy of the device in eliminating cancer has yet to be established, ...

Endeavor Health Edward Hospital in Naperville earned an “A” grade from The Leapfrog Group, a nonprofit watchdog organization that analyzes data related to health care. Leapfrog recently released its ...

Siena men's lacrosse's new coach Liam Gleason answers questions during a news conference Thursday June 28, 2018 in Loudonville. New Siena men's lacrosse coach, Liam Gleason, left, arrives with John ...

The clinical heterogeneity of needle biopsy (Bx)3 + 4 presents uncertainty to active surveillance as a treatment option for prostate cancer (PCa) patients. This meta-analysis demonstrates that 23.4% ...

Two men have low-grade prostate cancer, limited Gleason 3+3 disease, and both are good candidates for active surveillance (AS). But their risk may not be the same, a new Brady study has found.

Study data, published in JAMA and presented at EMUC 2025, suggest ExactVu is potential MRI alternative for image-guided prostate biopsy “These results are a game-changer for urologists and patients, ...